Home
Conditions
Recurrent Cervical Carcinoma

Clinical trial condition

Recurrent Cervical Carcinoma

Explore clinical trials studying Recurrent Cervical Carcinoma. Study availability and eligibility vary by location and protocol.

32 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Cervical Carcinoma trial results

Recruiting

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

NCT06157151

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

National Institute of Health Bethesda, Maryland, United States

University of Washington Seattle, Washington, United States

View Trial Details

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

NCT06349642

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

NCT03968406

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +46 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

NCT02257528

Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Female Urogenital Diseases, +16 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 331 locations

View Trial Details

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

View all 1410 locations

View Trial Details

Active, not recruiting

Dostarlimab and Cobolimab in Advanced Cervical Cancer

NCT06238635

Conditions: Advanced Cervical Carcinoma, Cervical Cancer, Female Urogenital Diseases, +15 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

NCT04574635

Conditions: Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Female Urogenital Diseases, +37 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

NCT03508570

Conditions: Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +58 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

NCT03452332

Conditions: Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, +50 more
Locations: UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

NCT03816553

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Guangzhou Panyu Central Hospital Guangzhou, Guangdong, China

The First affiliated Hospital of Sun Yat-sen University Guanzhou, Guangdong, China

View Trial Details

Recurrent Cervical Carcinoma

Recurrent Cervical Carcinoma trial results

Related conditions